Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corneal Collagen Cross-Linking for Keratoconus and Ectasia
NCT00679666Phase 3Withdrawn
- Sponsor
- The Ohio State University
- Start
- Apr 2008
- Primary completion
- Apr 2010
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of riboflavin in keratoconus and corneal ectasia (2 arms), sponsored by The Ohio State University. Primary endpoint: Change in keratometry at 3 months. Planned start Apr 2008; status: withdrawn.
02
Drugs
riboflavin
03
Conditions
keratoconuscorneal ectasia
Beyond the preview
Go deeper on NCT00679666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00679666.